Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KANK1-NTRK2 fusion
i
Other names:
NTRK2, TRKB, Neurotrophic tyrosine kinase, receptor, type 2, KANK1, KN Motif And Ankyrin Repeat Domains 1, KANK, KIAA0172, ANKRD15, KN Motif And Ankyrin Repeat Domain-Containing Protein 1, Ankyrin Repeat Domain-Containing Protein 15, Kidney Ankyrin Repeat-Containing Protein, Ankyrin Repeat Domain 15, CPSQ2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4915
;
23189
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
NTRK2 fusion (88)
ETV6-NTRK2 fusion (1)
NACC2-NTRK2 fusion (1)
STRN-NTRK2 fusion (1)
NTRK2 fusion (88)
ETV6-NTRK2 fusion (1)
NACC2-NTRK2 fusion (1)
STRN-NTRK2 fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KANK1-NTRK2 fusion
Soft Tissue Sarcoma
KANK1-NTRK2 fusion
Soft Tissue Sarcoma
crizotinib
Sensitive: C3 – Early Trials
crizotinib
Sensitive
:
C3
crizotinib
Sensitive: C3 – Early Trials
crizotinib
Sensitive
:
C3
KANK1-NTRK2 fusion
Osteosarcoma
KANK1-NTRK2 fusion
Osteosarcoma
crizotinib
Sensitive: C3 – Early Trials
crizotinib
Sensitive
:
C3
crizotinib
Sensitive: C3 – Early Trials
crizotinib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.